Log in to save to my catalogue

A monoclonal antibody targeted against epidermal growth factor receptor variant III enhances cisplat...

A monoclonal antibody targeted against epidermal growth factor receptor variant III enhances cisplat...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_889193818

A monoclonal antibody targeted against epidermal growth factor receptor variant III enhances cisplatin efficiency

About this item

Full title

A monoclonal antibody targeted against epidermal growth factor receptor variant III enhances cisplatin efficiency

Publisher

Berlin/Heidelberg: Springer-Verlag

Journal title

Journal of cancer research and clinical oncology, 2011-10, Vol.137 (10), p.1455-1461

Language

English

Formats

Publication information

Publisher

Berlin/Heidelberg: Springer-Verlag

More information

Scope and Contents

Contents

Purpose
To investigate the effect of a monoclonal antibody (CH12), targeted against epidermal growth factor receptor type III variant (EGFRvIII), on human ovarian cancer cells when administered in combination with cisplatin chemotherapy.
Methods
Western blot and reverse transcription polymerase chain reaction (RT–PCR) were used to determin...

Alternative Titles

Full title

A monoclonal antibody targeted against epidermal growth factor receptor variant III enhances cisplatin efficiency

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_889193818

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_889193818

Other Identifiers

ISSN

0171-5216

E-ISSN

1432-1335

DOI

10.1007/s00432-011-1018-9

How to access this item